Affluent Medical SA

Paris Stock Exchange AFME.PA

Affluent Medical SA Interest Coverage Ratio for the year ending December 31, 2023: -39.18

Affluent Medical SA Interest Coverage Ratio is -39.18 for the year ending December 31, 2023, a -186.28% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.

Affluent Medical SA Interest Coverage Ratio for the year ending December 31, 2022 was -13.69, a -214.18% change year over year.
Affluent Medical SA Interest Coverage Ratio for the year ending December 31, 2021 was -4.36, a 23.83% change year over year.
Affluent Medical SA Interest Coverage Ratio for the year ending December 31, 2020 was -5.72, a 27.26% change year over year.
Affluent Medical SA Interest Coverage Ratio for the year ending December 31, 2019 was -7.86, a 87.30% change year over year.

Key data

Date	Interest Coverage Ratio	Debt to Equity Ratio	Interest Expense To Sales	Inventory Turnover Ratio

Paris Stock Exchange: AFME.PA

Affluent Medical SA

CEO	Sebastien Ladet Ph.D.
IPO Date	June 14, 2021
Location	France
Headquarters	320, avenue Archimède
Employees	66
Sector	Health Care
Industries Medical Instruments Biotechnology Pharmaceuticals

Description

Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.

Key trends

Past 5 years